Taletrectinib is a potent, orally active, and next-generation selective ROS1/NTRK inhibitor. Taletrectinib potently inhibits recombinant ROS1, NTRK1,…
About Aumolertinib Aumseqa (INN: Aumolertinib) (previously known as almonertinib) is a EGFR tyrosine kinase inhibitor targeting…
Sunvozertinib (DZD9008) is an oral, potent, irreversible, and selective EGFR TKI targeting EGFR exon20ins as well as EGFR sensitizing,…
About Vebreltinib Vebreltinib (also known as bozitinib) is a pharmaceutical drug used for the treatment of…
INDICATIONS AND USAGE Afatinib is a kinase inhibitor indicated for: • First-line treatment of patients with…
INDICATIONS AND USAGE Erlotinib is a kinase inhibitor indicated for: · The treatment of patients with metastatic…
INDICATIONS AND USAGE Dacomitinib is a kinase inhibitor indicated for the first-line treatment of patients with…
TYVYT® (sintilimab injection) is a fully human IgG4 monoclonal antibody, which specifically binds to PD-1 expressed on…
About Savolitinib Savolitinib is an oral, potent, and highly selective MET TKI that has demonstrated clinical…
About Furmonertinib Furmonertinib Mesilate acts as an anti-cancer agent. It is formulated as tablets for oral…
About Tepotinib Tepotinib is a kinase inhibitor directed against MET, including variants with exon 14 skipping…
About Cejemly® (Sugemalimab) The anti-PD-L1 monoclonal antibody sugemalimab was discovered by CStone using the OmniRat® transgenic animal…
ABout Crizotinib Crizotinib is a prescription medicine used to treat people with non-small cell lung cancer…
About Repotrectinib Repotrectinib is an anti-cancer medication used for the treatment of non-small cell lung cancer. It is taken by mouth. Repotrectinib is…
Serplulimab, a recombinant humanised anti-PD-1 monoclonal antibody (mAb) injection, is the first innovative monoclonal antibody developed…
Trametinib is a kinase inhibitor used alone or in combination with dabrafenib to treat patients with cancers…
Copyright © 2021-2022 LienTeh.net All rights reserved.
